Portfolio

Professor Christina Doyle is a material scientist by training. She is currently visiting Professor at the Universities of Exeter School of Engineering and Surrey Materials Institute. Since graduating she has focussed on medical technology, first leading a biomaterials research group at the University of London and then since 1990 working in various major corporations, leading their international R&D groups.

She directed development plans, acquisition, technology transfer and route to market for many new technologies and materials. She was VP Applied Research for Stryker International until 2000, then joining the BTG plc Medical Technology group with responsibility for development. She now either sits or has sat as a non-executive director on the boards of several growth-phase businesses such as BoneSupport SE and Tissue Regenix Ltd.

Christina has an MBA (Open), PhD, MSc, and BSc (Hons) and is a Chartered Engineer. She maintains an interest in UK science policy and funding, sitting on the UK EPSRC strategic User Panel (2001-6) and now a member of the Research Council’s Strategic Advisory Teams (Healthcare and Interdisciplinary).

Fellow of Institute of Materials (Executive Council Member 1992–1996), Chartered
Engineer, European Engineer, Fellow of Biological Engineering Society, Member
Orthopaedic Research Society (USA), Member European Society of Biomaterials, US
Soc Biomaterials, UK Biomaterials Network, Research Council (EPSRC) Strategic User
Panel (UP) member, DTI MedLINK Programme Management (medical technology).
Advisor to UK government DTI on medical technology & bio-nanotechnology
programmes
SKILLS
· Deep and broad knowledge-base of global medical device business (orthopaedics,
spine, dental, drug-delivery, wound care, cardiovascular, urology, tissue engineering,
nanotechnology).
· Preparation of clear and informed expert reports for medical device cases
· Preparation/implementation of business plans to facilitate investment decisions
· Ability to identify and source early-stage technologies with commercial potential

Medical Devices and Biomaterials
· Gained several regulatory approvals in EU
· Independent expert for cases regarding such issues as materials failure, device failure,
tampering and surgeon error in UK, USA and Australia
· Successfully bringing innovations through the technology transfer cycle. These have
included osteobiologics, dental cement, ceramic bearing, polymer-composite cups,
spinal disc, hip fracture device, urinary catheter.
· Initiated & led the technical marketing/sales effort that led to sales of over >$50
million in 6 years (1995-2000)
· Represented UK in bio-nanotechnology overseas missions
· Applied combined knowledge of engineering, clinical practice, development and
marketing.